Konkle B A, Ginsburg D
Department of Medicine, University of Michigan Medical School, Ann Arbor.
J Clin Invest. 1988 Aug;82(2):579-85. doi: 10.1172/JCI113635.
Plasminogen activator inhibitor-1 (PAI-1) is a specific and rapid inhibitor of tissue plasminogen activator (tPA) and urokinase. Clinical studies suggest that PAI-1 may play a crucial role in the regulation of fibrinolysis. A number of factors modulate PAI-1 activity in endothelial cell culture, and the isolation of PAI-1 cDNA now allows study of PAI-1 regulation at the mRNA level. We examined the effect of endothelial cell growth factor (ECGF) and heparin on PAI-1 expression in human umbilical vein endothelial cell (HUVEC) culture. The addition of ECGF and heparin to HUVEC cultures results in a 3-10-fold decrease in the PAI-1 activity secreted into the conditioned media. This effect is mediated at the mRNA level. A decrease in PAI-1 is also seen with higher concentrations of ECGF alone, but is greatly enhanced by the addition of heparin. No significant change in tPA antigen or mRNA levels was observed.
纤溶酶原激活物抑制剂-1(PAI-1)是组织纤溶酶原激活物(tPA)和尿激酶的一种特异性快速抑制剂。临床研究表明,PAI-1可能在纤维蛋白溶解调节中起关键作用。许多因素可调节内皮细胞培养中PAI-1的活性,而PAI-1 cDNA的分离现在使得能够在mRNA水平研究PAI-1的调节。我们研究了内皮细胞生长因子(ECGF)和肝素对人脐静脉内皮细胞(HUVEC)培养中PAI-1表达的影响。向HUVEC培养物中添加ECGF和肝素会导致分泌到条件培养基中的PAI-1活性降低3至10倍。这种作用是在mRNA水平介导的。单独使用较高浓度的ECGF时也可见PAI-1减少,但加入肝素后会大大增强。未观察到tPA抗原或mRNA水平有显著变化。